GEHC 財務： GE Healthcare Technologies Inc AI 分析

Q: GE Healthcare Technologies Inc 的關鍵財務報表是什麼？

根據最新的財務報表（Form-10K），GE Healthcare Technologies Inc 的總資產為 $33,089，淨利潤為 $1,993

Q: GEHC 的關鍵財務比率是什麼？

GE Healthcare Technologies Inc 的流動比率為 1.34，淨利潤率為 10.13，每股銷售為 $42.85。

Q: GE Healthcare Technologies Inc 的收入按細分市場或地理位置如何劃分？

GE Healthcare Technologies Inc 最大收入來源為 Product，在最近的收益報告中收入為 13,075,000,000。就地區而言，USCAN 是 GE Healthcare Technologies Inc 的主要市場，收入為 8,981,000,000。

Q: GE Healthcare Technologies Inc 是否盈利？

是的，根據最新的財務報表，GE Healthcare Technologies Inc 的淨利潤為 $1,993

Q: GE Healthcare Technologies Inc 有負債嗎？

是的，GE Healthcare Technologies Inc 的負債為 24,643

Q: GE Healthcare Technologies Inc 的流通股有多少？

GE Healthcare Technologies Inc 的總流通股為 456.95

首頁

股票

GEHC

GEHC 財務

GE Healthcare Technologies Inc

$78.83

-3.57%

$-2.92

收盤價：Jan 20, 16:00:00 GMT-5

$79.03

0.25%

$0.2

盤前：Jan 21, 07:44:00 GMT-5

概觀預測收益股利財務狀況

360

報告

B-

最終分數

關鍵數據

前收市價

$81.75

開盤價

$79.68

當日範圍

$78.32 - $80

52週區間

$57.65 - $94.8

交易量

5.4M

平均成交量

3.4M

每股盈餘 (TTM)

4.84

股息收益率

0.16%

市值

$35.9B

什麼是 GEHC？

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

功能特性

交易策略

資源

市場

收入

資產負債表

現金流量

年度

每季

GEHC 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	20,246	19,672	19,552	18,341	17,585	17,164
營收年增率 (YoY)	4%	1%	7%	4%	2%	3%
營收成本	11,986	11,467	11,630	11,162	10,411	10,397
毛利	8,260	8,205	7,922	7,179	7,174	6,767
銷售、一般及管理費用	4,244	4,269	4,282	3,631	3,563	3,237
研發	1,282	1,311	1,205	1,026	816	810
營業費用	5,523	5,580	5,487	4,657	4,379	4,047
其他非營業收入 (費用)	369	453	431	63	181	112
稅前淨利	2,782	2,581	2,361	2,512	2,875	2,710
所得稅費用	492	531	743	563	600	652
淨利	2,217	1,993	1,385	1,916	2,247	13,846
淨利成長	32%	44%	-28%	-15%	-84%	809%
稀釋後流通股數	457	459	458	453.92	454.71	454.71
股數年變動 (YoY)	0%	0%	1%	0%	0%	0%
每股盈餘 (稀釋)	4.83	4.34	3.03	4.22	4.94	30.45
每股盈餘成長率	32%	43%	-28%	-15%	-84%	809%
自由現金流	1,400	1,550	1,714	1,803	1,359	2,359
每股自由現金流	--	--	--	--	--	--
毛利率	40.79%	41.7%	40.51%	39.14%	40.79%	39.42%
營業利益率	13.51%	13.34%	12.45%	13.75%	15.89%	15.84%
淨利率	10.95%	10.13%	7.08%	10.44%	12.77%	80.66%
自由現金流利潤率	6.91%	7.87%	8.76%	9.83%	7.72%	13.74%
EBITDA	3,309	3,205	3,045	3,155	3,420	3,350
EBITDA 利潤率	16.34%	16.29%	15.57%	17.2%	19.44%	19.51%
EBITDA 中的折舊與攤銷	572	580	610	633	625	630
EBIT	2,737	2,625	2,435	2,522	2,795	2,720
EBIT 利潤率	13.51%	13.34%	12.45%	13.75%	15.89%	15.84%
有效稅率	17.68%	20.57%	31.46%	22.41%	20.86%	24.05%

Follow-Up Questions

GE Healthcare Technologies Inc 的關鍵財務報表是什麼？



GEHC 的關鍵財務比率是什麼？



GE Healthcare Technologies Inc 的收入按細分市場或地理位置如何劃分？



GE Healthcare Technologies Inc 是否盈利？



GE Healthcare Technologies Inc 有負債嗎？



GE Healthcare Technologies Inc 的流通股有多少？



GE Healthcare Technologies Inc（GEHC）價格

GEHC 股價走勢圖